Merck CMO Sells $1.18M in Company Stock
Merck & Co., Inc.
Subscribe to track MRK
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Merck CMO Sells $1.18M in Company Stock
Company: Merck & Co., Inc. (MRK) Form: 4 | Filed: 2026-02-09 Significance: Low
Insider: Guindo Chirfi Title: Chief Marketing Officer | Relationship: Officer
Transaction: • Type: Sale • Shares: 10,000 • Price: $118.41 • Value: $1,184,101 • Owned After: 70,615
Key Insight: A $1.18M sale by the Chief Marketing Officer. While a large absolute number, the transaction is immaterial relative to Merck's $302.6B market cap, representing less than 0.001% of shares outstanding.
Comprehensive Analysis
SEC Filing Analysis: Merck & Co., Inc. (MRK)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The Chief Marketing Officer sold $1.18 million worth of company stock, a transaction that is immaterial given Merck's massive market capitalization.
- Market Impact: The sale is too small to have any meaningful impact on the stock price or market sentiment.
Company Information
| Field | Value |
|---|---|
| Company | Merck & Co., Inc. |
| Ticker Symbol | MRK |
| CIK | 0000310158 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | Guindo Chirfi |
| CIK | 0001722753 |
| Title/Position | Chief Marketing Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2026-02-09 |
| Transaction Code | S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 10,000 |
| Price Per Share | $118.4101 |
| Total Value | $1,184,101 |
| Shares Owned After | 70,615.127 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $1,184,101 |
| % of Market Cap | 0.00039% |
| Shares Transacted | 10,000 |
| % of Shares Outstanding | 0.00040% |
| Post-Transaction Ownership | 70,615 shares (0.0028% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a mega-cap company like Merck with a market capitalization of over $302 billion, a transaction of $1.18 million is considered routine and financially insignificant.
- Ownership Concentration: The sale represents approximately 12.4% of the insider's prior holdings. While a notable portion for the individual, the insider's total ownership remains very small relative to the total shares outstanding.
- Transaction Significance: The transaction's value is less than 0.001% of the company's market cap and involves less than 0.001% of its outstanding shares. These metrics firmly place the transaction in the 'Low' significance category.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is too small to be considered a signal about the company's future prospects. Such sales by executives are common for personal financial management, diversification, or tax planning.
Volume & Sentiment
- Expected Volume Impact: Negligible. The 10,000 shares transacted are a tiny fraction of Merck's daily trading volume.
- Sentiment Indicator: Neutral. The market is unlikely to react to a sale of this size from a single executive at a company of this scale.
Additional Context
Transaction Notes
- The sale was executed at a weighted average price of $118.4101, with prices ranging from $118.4000 to $118.4502.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
